This research compound was 1st noted by Hoffman-La Roche in 2009. It’s one of quite a few benzodiazepines inside the imidazobenzodiazepine subgroup assumed to offer nootropic Advantages. This compound is taken into account an intermediate-acting hypnotic with a very fast onset of consequences. The consequences of nimetazepam is usually felt https://scottx122zvp7.answerblogs.com/profile